跳至主要内容
临床试验/NCT05521711
NCT05521711招募中不适用

TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation

Hamilton Health Sciences Corporation1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Eliciting dose thresholds to food challenge

研究概览

简要总结

Tree nut immunotherapy Route Assessment and DEvelopment (TRADE) is a randomized controlled trial that evaluates the efficacy and safety of sublingual immunotherapy and lower, more tolerable, doses of oral immunotherapy than currently in use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Allergic to tree nut with baseline threshold of 444 mg protein or less and provides consent, and where applicable, assent.

排除标准

  • History of anaphylaxis to tree nut severe enough to cause shock, syncope, or intubation
  • Eosinophilic or other inflammatory gastrointestinal disease within the past 2 years
  • Severe (GINA severity class 5) or uncontrolled asthma including exacerbation within past 6 months
  • Use of biologics, other food immunotherapy or experimental treatment in past 6 months.
  • Ongoing other allergic diseases severe enough to preclude discontinuing antihistamines for 7 days prior to assessment visits
  • Pregnancy or significant medical condition (e.g., liver, kidney, gastrointestinal, cardiovascular, hematologic, or pulmonary disease; allergy to the oat-based placebo) which would put the participant at excessive risk for food allergic reactions as judged by local investigator

结局指标

主要结局

Eliciting dose thresholds to food challenge

时间窗: 1 year

次要结局

  • Quality of life(1 Year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验